HIFU Therapy

High Intensity Focused Ultrasound (HIFU) for Treating Localized Prostate Cancer

HIFU is an emerging technology that is rapidly taking its place among the other therapies which target and cure prostate cancer. HIFU has the advantage of treating the cancer equally as well as radiation and surgery without subjecting patient to diminished quality of life. In past 10 years HIFU has become increasingly utilized throughout the world because of its effective ability to treat the patient.

HIFU is an approved therapy used to treat prostate cancer throughout Europe, Australia, Japan, the Far East, South America and all other areas of the civilized world. It is currently pending FDA approval in the United States and is in the final phase of clinical trials. Once the trials are completed and approved by FDA, HIFU will be the only FDA–approved treatment for prostate cancer. All other treatments have been grandfathered in and never examined through formal FDA trials.

Outcomes for HIFU therapy are exactly equivalent to surgery and radiation, which provides hope for men to successfully overcome prostate cancer, without adversly threatening thir quality of life.

Currently HIFU is available to American men through International HIFU. Treatment centers have been established by International HIFU and HIFU training for urologists has been conducted in order to allow American urologists to take their pateients to International HIFU treatment centers. While outside the territorial Unites States, these treatment centers are conveniently located in Nassau; Bermuda; Cancun and Puerta Vallerta Mexico; and Niagara Falls, Ontario, Toronto, and Montreal Canada. Each center is totally compliant with U.S. standards and is equipped to provide treatments using the the Sonablate 500, the most advanced HIFU instrument.

Dr. Peter Sinaiko is one of the most experienced HIFU urologists in the United States and is available to perform the procedure at any of the International HIFU locations. He has been actively diagnosing and treating prostate cancer since 1976. Over that period of time he has treated several thousand patients with prostate cancer, utilizing all of the various therapies available. This has afforded him a keen perspective in diagnosing and managing men with prostate cancer. His extensive experience has allowed him the judgement necessary to recommend and treat each individual patient in a way that will satisfy that patient’s needs.